Table 2 Recurrences
number | Treatment upon recurrence | |||||||
|---|---|---|---|---|---|---|---|---|
Local recurrence | 4 | ∗ Mastectomy only ∗ Lumpectomy + SLNB + WBI (40.05 Gy/15Fx) ∗ Two patients -Letrozole alone | ||||||
Locoregional recurrence | 2 | ∗ Mastectomy + ALND + CW and low axilla RT (26 Gy/5Fx) ∗ Lumpectomy + ALND and Breast + supra/axilla RT (40.05 Gy/15Fx and boost 13.35/5Fx) | ||||||
Distant recurrence | 1 | ∗ Chemotherapy | ||||||
Recurred patient’s characteristics at initial diagnosis | ||||||||
Patient number | Age at cancer diagnosis (years) | Time to recurrence (months) | Histologic type | Tumor size (mm) | Margins at resection | LVI** | KI67** | Receipt of Endocrine treatment |
1 | 80 | 68 | Ductal | 21 | Negative | No | 60 | Yes |
2 | 81 | 47 | Ductal | 15 | Negative | - | 10 | Yes |
3 | 87 | 57 | Ductal | 20 | Negative | No | 10 | Yes |
4 | 84 | 64 | Ductal | 7 | negative | No | - | Yes |
5 | 84 | 64 | Mucinous | 28 | Negative | - | - | Yes |
6 | 81 | 136 | Ductal | 13 | Negative | No | 12 | Yes |
7 | 91 | 47 | Ductal | 25 | Negative | No | 10 | No |